Fundraising FoxNorth Texas Renal Management VI
Dallas, US · Founded 2017 · Texas LLC
Find your way into North Texas Renal Management VI
Sign up to see every warm intro you have to North Texas Renal Management VI
- Paths you didn't know you had: your email and LinkedIn already hold routes to the North Texas Renal Management VI team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SM
Steven M. Gieser, M.D.Executive
AS
Anupkumar Shetty, M.D.Named on SEC filing
AL
Alexander Liang, M.D.Named on SEC filing
JM
Joris M Schuller, Jr., M.D.Named on SEC filing
JK
Jyothsna Kodali, M.D.Named on SEC filing
Board
AK
Ali Khalil, M.D.Board director
DR
Daniel Richey, D.O.Board director
Reported raises · per SEC filings
Form D private placements$619.3K disclosed across 3 rounds · 2018–2025
▶$76.5KraisedApr 2026 · 1 investors · Other Health CareRule 506(b)
▶$76.5KraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven GieserExecutive Officer, Director
- Ali KhalilDirector
- Daniel M. RicheyDirector
- Geoffrey S. WalkerExecutive Officer, Director
- Jyothsna KodaliExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $76.5K
- First sale
- Dec 2025
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$54.2KraisedJan 2025 · 1 investors · Other Health CareRule 506(b)
▶$54.2KraisedJan 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ali Khalil, M.D.Director
- Daniel Richey, D.O.Director
- Geoffrey Walker, M.D.Executive Officer, Director
- Steven M. Gieser, M.D.Executive Officer, Director
- Jyothsna Kodali, M.D.Director
- Offering amount
- $867.2K
- Amount sold
- $54.2K
- First sale
- Dec 2024
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$488.6KraisedNov 2018 · 63 investors · Other Health CareRule 506(b)
▶$488.6KraisedNov 2018 · 63 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven Gieser, M.D.Executive Officer, Director
- Geoffrey Walker, M.D.Executive Officer, Director
- Anupkumar Shetty, M.D.Executive Officer, Director
- Alexander Liang, M.D.Director
- Joris M Schuller, Jr., M.D.Director
- Offering amount
- $707.4K
- Amount sold
- $488.6K
- Minimum investment
- $4K
- First sale
- Oct 2018
- Incorporated
- Limited Liability Company, Texas, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has North Texas Renal Management VI raised?
- North Texas Renal Management VI has disclosed $619.3K raised across 3 rounds.
- Where is North Texas Renal Management VI headquartered?
- North Texas Renal Management VI is headquartered in Dallas, US.